Mirati Therapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
MRTX on Nasdaq
Location
3545 Cray Court, San Diego, California

Insiders trading volume in the past year

Mirati Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
EcoR1 Capital, LLC 10%+ Owner $437 M Dec 18, 2023
David D. Meek Chief Executive Officer, Director $8.92 M Jan 20, 2023
Laurie Stelzer Chief Financial Officer $6.04 M Aug 9, 2023
S. Reed SVP, Chief Accounting Officer $907 K Jan 14, 2022
Henry J. Fuchs Director $618 K Jan 20, 2023
Craig A. Johnson Director Jan 23, 2024
Aaron I. Davis Director Jan 23, 2024
John Moriarty Chief Legal Officer Jan 23, 2024
Maria E. Martinez Director Jan 23, 2024
L. Carter Bruce Director Jan 23, 2024
Carol Giltner Gallagher Director Jan 23, 2024
Jamie Christensen EVP & Chief Scientific Officer -$407 K Jan 23, 2024
Charles M. Baum Founder, President, and CEO, Director Jan 23, 2024
Benjamin Hickey EVP, Chief Commercial Officer -$343 K Jan 23, 2024
Julie M. Cherrington Director Jan 23, 2024
Faheem Hasnain Director +$300 K Jan 23, 2024
Shalini Sharp Director Jan 23, 2024
Aaron Ondrey Chief Financial Officer Jan 23, 2024
Alan B. Sandler Chief Medical Officer Jan 23, 2024
Boxer Capital, LLC Other* +$70 M Jan 23, 2024

Recent Insider Transactions by Companies or Individuals for Mirati Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership